Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +17819995354 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Ezetimibe phenoxy glucuronide；Ezetimibe β-D-glucuronide;Ezetimibe glucuronide | C30H29F2NO9 | 190448-57-8 | Details |
| Evogliptin tartrate；DA-1229 tartrate | C19H26F3N3O3 · (C4H6O6) | 1222102-51-3 | Details |
| Shikonin；Isoarnebin 4;Anchusa acid;NSC 252844;Alkanna Red;(+)-Shikonin;C.I. 75535 | C16H16O5 | 517-89-5 | Details |
| Ezetimibe-d4；SCH 58235 D4;Ezetimibe D4 | C24H17D4F2NO3 | 1093659-90-5 | Details |
| Ezetimibe ketone；EZM-K | C24H19F2NO3 | 191330-56-0 | Details |
| F-1 | C22H27ClN8O3S | 2244775-31-1 | Details |
| Exatecan | C24H22FN3O4 | 171335-80-1 | Details |
| Etimizol | C9H14N4O2 | 64-99-3 | Details |
| FAAH inhibitor 1 | C24H23N3O3S3 | 326866-17-5 | Details |
| FAAH-IN-1 | C20H19ClN4OS | 1242441-47-9 | Details |
| Etoricoxib-d4；MK-0663 D4;Etoricoxib D4;L-791456 D4 | C18H11ClD4N2O2S | 1131345-14-6 | Details |
| Etiracetam；UCB 6474 | C8H14N2O2 | 33996-58-6 | Details |
| Etravirine D4；TMC-125 D4;R-165335 D4 | C20H11BrD4N6O | 1142095-93-9 | Details |
| Ezetimibe phenoxy glucuronide-D4；Ezetimibe glucuronide-D4;Ezetimibe β-D-glucuronide-D4 | C30H25D4F2NO9 | 1426174-41-5 | Details |
| Dxd | C26H24FN3O6 | 1599440-33-1 | Details |
| Etamicastat hydrochloride | C14H16ClF2N3OS | 677773-32-9 | Details |
| Ethacizine hydrochloride | C22H28ClN3O3S | 57530-40-2 | Details |
| Endothelial lipase inhibitor-1 | C22H22N4O4 | 1466427-02-0 | Details |
| Enocyanin | C15H11O+ | 11029-12-2 | Details |
| ENS-163 phosphate；Sandoz ENS 163 phosphate;Thiopilocarpine phosphate;ENS 213-163 | C11H19N2O5PS | 117707-51-4 | Details |
| Enzalutamide-d3；Enzalutamide D3;MDV3100 D3 | C21H13D3F4N4O2S | 1443331-82-5 | Details |
| EMT inhibitor-1 | C12H12Cl2N2O2S | 1638526-21-2 | Details |
| EHNA hydrochloride | C14H24ClN5O | 58337-38-5 | Details |
| EML741 | C31H49N5O2 | 2328074-38-8 | Details |
| Clorgyline hydrochloride | C13H16Cl3NO | 17780-75-5 | Details |
| EMPA | C23H26N4O4S | 680590-49-2 | Details |
| Cefprozil monohydrate | C18H21N3O6S | 121123-17-9 | Details |
| (R)-Elagolix | C32H30F5N3O5 | 834153-87-6 | Details |
| Elenbecestat | C19H18F3N5O2S | 1388651-30-6 | Details |
| ELN318463 racemate | C19H20BrClN2O3S | 851599-82-1 | Details |
| Elubrixin | C17H17Cl2FN4O4S | 688763-64-6 | Details |
| Elinogrel；PRT060128 | C20H15ClFN5O5S2 | 936500-94-6 | Details |
| ELN318463；ELN 318463 | C19H20BrClN2O3S | 851600-86-7 | Details |
| EMDT oxalate | C15H22N2O | 263744-72-5 | Details |
| EIPA hydrochloride；L593754 hydrochloride;MH 12-43 hydrochloride | C11H19Cl2N7O | 1345839-28-2 | Details |
| eIF4A3-IN-2 | C25H19Br2ClN4O2 | 2095677-20-4 | Details |
| EHMT2-IN-2 | C21H22N6O | 2230850-47-0 | Details |
| Rineterkib | C26H27BrF3N5O2 | 1715025-32-3 | Details |
| EPAC 5376753 | C15H8Cl2N2O3S | 302826-61-5 | Details |
| Eravacycline dihydrochloride；TP-434-046;TP-434 dihydrochloride | C27H32ClFN4O8 | 1334714-66-7 | Details |
| Eplivanserin | C19H21FN2O2 | 130579-75-8 | Details |
| Camptothecin；CPT;NSC-100880;(S)-(+)-Camptothecin;Campathecin | C20H16N2O4 | 7689-03-4 | Details |
| EOAI3402143 | C25H28Cl2N4O3 | 1699750-95-2 | Details |
| EP1013；F1013 | C18H23FN2O6 | 223568-55-6 | Details |
| Entacapone sodium salt | C14H14N3NaO5 | 1047659-02-8 | Details |
| ent-Tadalafil；ent-IC-351 | C22H19N3O4 | 629652-72-8 | Details |
| ERRα antagonist-1 | C21H19N3S2 | 1072145-33-5 | Details |
| ERK2 IN-1 | C36H34FN7O2S | 1093061-47-2 | Details |
| Erlotinib-d6；NSC 718781 D6;OSI-774 D6;Erlotinib D6;CP-358774 D6 | C22H23N3O4 | 1034651-23-4 | Details |
| Cephalothin sodium | C16H16N2O6S2.Na | 58-71-9 | Details |
| ERK1/2 inhibitor 1 | C29H32ClN5O4 | 2095719-90-5 | Details |
| Eliglustat hemitartrate | C50H78N4O14 | 928659-70-5 | Details |
| eIF4A3-IN-1 | C29H23BrClN5O2 | 2095486-67-0 | Details |
| ε-Viniferin | C28H22O6 | 62218-08-0 | Details |
| Episilvestrol | C34H38O13 | 697235-39-5 | Details |
| Epertinib；S-22611 | C30H27ClFN5O3 | 908305-13-5 | Details |
| Equisetin | C22H31NO4 | 57749-43-6 | Details |
| ERB-196；WAY-202196 | C17H10FNO2 | 550997-55-2 | Details |
| ER21355 | C22H21ClN4O4 | 150452-18-9 | Details |
| ERAP1-IN-1 | C20H21F3N2O5S | 865273-97-8 | Details |
| Eriosematin | C19H20O4 | 168010-17-1 | Details |
| Eravacycline；TP-434 | C27H31FN4O8 | 1207283-85-9 | Details |
| Ethyl tosylcarbamate | C10H13NO4S | 5577-13-9 | Details |
| Enalapril D5 maleate；MK-421 D5 maleate | C24H27D5N2O9 | 349554-02-5 | Details |
| Enalaprilat-d5 sodium；Enalaprilat D5 Sodium Salt;MK-422 D5 Sodium Salt | C18H18D5N2NaO5 | 1356922-29-6 | Details |
| Enalaprilat D5；MK-422 D5 | C18H19D5N2O5 | 349554-00-3 | Details |
| Eicosatetraynoic acid；ETYA | C20H24O2 | 1191-85-1 | Details |
| EML4-ALK kinase inhibitor 1 | C31H48N8O3 | 1373409-08-5 | Details |
| EMD638683 R-Form | C18H18F2N2O4 | 1184940-47-3 | Details |
| Embramine | C18H22BrNO | 3565-72-8 | Details |
| EMD638683 S-Form | C18H18F2N2O4 | 1184940-46-2 | Details |
| Emixustat；ACU-4429 | C16H25NO2 | 1141777-14-1 | Details |
| EMT inhibitor-2 | C24H26N2O8 | 2232228-60-1 | Details |
| Emixustat hydrochloride；ACU-4429 hydrochloride | C16H26ClNO2 | 1141934-97-5 | Details |
| Emtricitabine S-oxide；Emtricitabine sulfoxide;Emtricitabine Degradant-III | C8H10FN3O4S | 152128-77-3 | Details |
| Rasagiline | C12H13N | 136236-51-6 | Details |
| EN6 | C19H14F2N4O2 | 1808714-73-9 | Details |
| Enazadrem | C18H25N3O | 107361-33-1 | Details |
| Endomorphin 2 TFA | C34H38F3N5O7 | 1276124-00-5 | Details |
| Enniatin A1 | C35H61N3O9 | 4530-21-6 | Details |
| Enniatin complex | C36H63N3O9.C35H61N3O9.C34H59N3O9.C33H57N3O9 | 11113-62-5 | Details |
| ent-Ezetimibe | C24H21F2NO3 | 1376614-99-1 | Details |
| Dacarbazine | C6H10N6O | 4342-03-4 | Details |
| EPI-589 | C14H19NO4 | 1147883-03-1 | Details |
| Eplivanserin (mixture)；SR-46349 (mixture);Eplivanserin mixture | C19H21FN2O2 | 130581-13-4 | Details |
| Endoxifen (E-isomer) | C25H27NO2 | 114828-90-9 | Details |
| ESI-08 | C20H23N3OS | 301177-43-5 | Details |
| Giredestrant tartrate | C31H37F5N4O7 | 2407529-33-1 | Details |
| Erysotrine | C19H23NO3 | 27740-43-8 | Details |
| Flumethasone | C22H28F2O5 | 2135-17-3 | Details |
| Podofilox | C22H22O8 | 518-28-5 | Details |
| Epertinib hydrochloride；S-22611 hydrochloride | C30H28Cl2FN5O3 | 2071195-74-7 | Details |
| EP4 receptor antagonist 1 | C23H21F3N4O3 | 2287259-07-6 | Details |
| Ethyl glucuronide | C8H14O7 | 17685-04-0 | Details |
| Erythromycin thiocyanate | C38H68N2O13S | 7704-67-8 | Details |
| p38 MAPK-IN-2 | C20H19ClFN5O2 | 635725-16-5 | Details |
| Ethacrynic acid D5 | C13H12Cl2O4 | 1330052-59-9 | Details |
| Etamicastat；BIA 5-453 | C14H15F2N3OS | 760173-05-5 | Details |
| Camizestrant | C24H28F4N6 | 2222844-89-3 | Details |
| Estradiol 3-sulfamate | C18H25NO4S | 172377-52-5 | Details |
| Product Total： Product Page： | ||||
| 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 | ||||